Introduction
Atherosclerosis can be considered the clinical endpoint of an inflammatory process and endothelial dysfunction. The binding of monocytes to the vascular endothelium is mediated by cross-linkage of cell adhesion molecules such as vascular cell adhesion molecule-1 (VCAM-1), E-selectin and/or intercellular adhesion molecule-1 (ICAM-1). The cell surface expression of these molecules is greatly increased in atherosclerotic lesions as a result of stimulation by proinflammatory cytokines such as tumor necrosis factor-␣ (TNF-␣ ). This cytokine has been selected as a stressor molecule in assessing the underlying mechanisms because it induces release and surface expression of cell adhesion molecules (CAMs), all of which contribute to the inflammatory process and endothelial dysfunction [1] [2] [3] [4] [5] . Further to this, there is in vivo evidence of increased VCAM-1 production in animal models of inflammation [3] .
Endothelial CAMs are known to be upregulated in atherosclerotic endothelium in an environment of circulating blood. They participate in leukocyte recruitment and, subsequently, in atherosclerosis progression and/or tissue damage [6] .
E-selectin is an inducible endothelial cell surface glycoprotein of the selectin family of adhesion molecules. It mediates the binding of neutrophils, eosinophils, monocytes and T lymphocytes to the endothelium [7] .
VCAM-1 and ICAM-1 are members of the immunoglobulin superfamily of CAMs. They mediate lymphocyte adhesion to major elements of the aortic wall such as endothelial cells and vascular smooth muscle cells [8] .
Induction of these three CAMs (VCAM, ICAM and E-selectin) by TNF-␣ is regulated at the level of gene transcription and requires the transcription nuclear factor-B (NF-B). Located in the cytoplasm of cells in an inactive form in close association with the inhibitor I B-␣ , NF-B binds to regulatory regions within promoter regions of the VCAM-1 gene [9, 10] via a process involving the phosphorylation and degradation of I B-␣ [10] [11] [12] .
In vitro studies indicate that VCAM-1, E-selectin and ICAM-1 are involved in the adhesion of eosinophils, monocytes and T lymphocytes via their cell surface [13] . Proteolytic cleavage of membrane-bound CAMs results in the release of their soluble forms -soluble CAMs (sCAMs), i.e. sVCAM-1, sE-selectin and sICAM-1 [6, [14] [15] [16] . [(E)3-[(4-methylphenyl)sulfonyl]-2-propenenitrile; BAY] is an anti-inflammatory and antioxidant molecule that selectively and nonreversibly inhibits the inducible phosphorylation of IkB-␣ in human pancreatic MIA PaCa-2 cancer cells [17] and endothelial cells [18] . As such, IkB-␣ avoids being degraded, resulting in a high level of cytosolic NF-B sequestered by IkB, together with decreased transcription and surface expression of the adhesion molecules [17] . However, the effect of BAY on VCAM-1 mRNA expression and its soluble protein (sVCAM-1) on endothelial dysfunction induced by TNF-␣ in human aortic endothelial cells (HAECs) has not, as yet, been evaluated in detail.
Some natural compounds or extracts of certain foods have been described as reversing endothelial dysfunction [2, 4, 13, 19, 20] . Prior to evaluating these functions in in vivo studies in animal and/or human subjects, in vitro cell models are developed to test the effects of these natural extracts (or compounds) based on the expression of cellular adhesion molecules in TNF-␣ -stimulated cells. As such, in vitro models facilitate the study of cells under controlled conditions and can be used as tools to examine the effects of various natural or synthetic pharmacologically active compounds.
Dietary factors play significant roles in the etiology of atherosclerosis by influencing inflammatory and endothelial dysfunction processes associated with the development of this disease. Vitamin E, especially the main fat-soluble dietary antioxidant alpha-tocopherol (AT), is very effective in reducing the adhesion of monocytes to HAECs in vivo and in vitro [21] .
Several studies have demonstrated that vitamin E decreases the cytokine-stimulated HAEC production of chemokines such as sVCAM-1, soluble intercellular cell adhesion molecule (sICAM-1) [3] , interleukine (IL)-6 and IL-8 [21] when stimulated with IL-␤ . Also, VCAM-1 mRNA expression levels are consistently elevated when incubated for between 6 and 24 h with TNF-␣ (10 ng/ml) and LPS (10 g/ml) in human umbilical vein endothelial cells (HUVECs), with the levels remaining high under these conditions [22, 23] . However, the effects of AT on endothelial dysfunction induced by TNF-␣ in HAECs are not well documented.
The aim of the present study was to test our hypothesis that, by modifying CAMs mRNA expression and sCAMs protein release, AT and BAY can improve endothelial dysfunction.
Materials and Methods

Cell Culture
HAECs (Cascade Biologics TM , Portland, Oreg., USA) at the 5th passage were seeded on Nunclon TM ⌬ surface 12-well plates (for the mRNA assays), 24-well plates (for the protein assays) or 96-well plates (for the adhesion assays) at a density of approximately 12 ! 10 3 of viable cells/ml. Cells were maintained for the first 24 h in complete cell culture medium (CM) composed of M-200 medium supplemented with 2% (v/v) low serum growth supplement, 10 mg/ml gentamicin, 0.25 mg/ml amphotericin B (both purchased from Invitrogen, Paisley, UK), 100 U/ml penicillin and 100 mg/ml of streptomycin (both from Labclinics, Barcelona, Spain). The cells were grown to confluence at 37 ° C in a humidified incubator (Heracell 150; Madrid, Spain) with atmosphere containing 5% CO 2 . The medium was replenished every 2 days with fresh CM. Viewed under an IMT2 microscope (Olympus, Barcelona, Spain), confluent monolayers displayed a typical monolayer phenotype of quiescent endothelial cells after 5 days in culture. All HAEC experiments were conducted at 37 ° C in a humidified atmosphere with 5% CO 2 .
Jurkat T cell lymphocytes were purchased from DSMZ GmbH (Braunschweig, Germany). Jurkat T cells were cultured in RPMI medium 1640 + Glutamax-I (Gibco, Spain) supplemented with 20% heat-inactivated foetal bovine serum (FBS) (PAA, Labclinics,) for the first 2 days followed by 10% FBS + 100 U/ml penicillin and 100 mg/ml streptomycin for growth and the scheduled experiments. The Jurkat T cells were maintained until the cell-cell adhesion assays.
HAECs were preincubated with AT (10, 25, 50, 75 and 150 M ; Sigma Chemical Co., St. Louis, Mo, USA) and the respective vehicle control (absolute ethanol, Panreac, Madrid, Spain) for 6 h, as recommended in the literature [23] [24] [25] [26] [27] . Then, as and when required, TNF-␣ (1 or 10 ng/ml; Calbiochem, Darmstadt, Germany) and BAY (0.1 or 1 M ; Merck, Darmstadt, Germany) were added to the cell culture medium for 24 h to induce cell stimulation. Finally, except for the cell-cell adhesion assays, supernatants were collected and stored at -20 ° C for batched measurements of the soluble forms of selected CAMs (sVCAM-1, sE-selectin and sICAM-1) and to measure the activity of the lactate dehydrogenase (LDH) released. Cells were lysed and stored at -80 ° C for batched TNF-␣ mRNA expression measurement. Fluorescent intensity was the method used to measure cell-cell adhesion.
Cell Viability and Cytotoxicity
Cell viability was assessed by morphology using phase-contrast microscopy and by trypan blue exclusion (Merck). Cell cytotoxicity was assessed with Cytotoxicity Detection Kit LDH (Roche Applied Science, Mannheim, Germany). Briefly, LDH enzyme is rapidly released into the cell culture supernatant when the plasma membrane is damaged. This results in a colorimetric reaction that can be measured at a wavelength of 492 nm.
For these experiments, TNF-␣ treatment was considered the maximum stress condition for the cells. The activity of LDH released from cells was measured in cell-free supernatants collected at two key stages of the experiment: after 6-hour incubation with AT and after 24-hour incubation with TNF-␣ (alone or in the presence of BAY) at the various concentrations. Results are expressed as mean absorbance and SD (error bars) of LDH produced by the cells under each treatment condition.
Analysis of CAMs mRNA Expression by Real-Time Quantitative Reverse Transcriptase Polymerase Chain
Reaction in HAECs Stimulated with TNF-␣ Dose-and time-course response experiments were performed by stimulating HAECs with TNF-␣ . Once the appropriate experimental conditions were established (i.e. the capacity to measure minimal decreases in CAMs mRNA expression that may be induced by the compounds under investigation: AT and BAY), we opted for 10 ng/ml (for E-selectin and ICAM-1) or 1 ng/ml (for VCAM-1) of TNF-stimulation over a culture period of 24 h, and BAY 1 M (for E-selectin and ICAM-1) or 0.1 M (for VCAM-1).
Cells were lysed with nucleic acid purification lysis solution and total RNA was isolated from cells using the ABI PRISM 6100 Nucleic Acid PrepStation extraction system (Applied Biosystems, Foster City, Calif., USA) according to the manufacturer's protocol. Total RNA was quantified using Quant-it TM RNA Assay Kit and Qubit TM fluorometer (Invitrogen). Using the 2720 Thermal
Cycler (Applied Biosystems), 0.5 g of total RNA was reverse transcribed to cDNA at 42 ° C for 50 min using random hexamers, SuperScript II reverse transcriptase and RNAse Out (Invitrogen) according to the manufacturer's protocol. To determine the amount of VCAM-1, E-selectin and ICAM-1 mRNA, semiquantitative RT-PCR was performed using the ABI PRISM 7900 Detection System (Applied Biosystems) with the following profile: 95 ° C denaturing (20 s) with 40 cycles of extension at 95 ° C (1 s) and 60 ° C (20 s). Each sample was analyzed in triplicate and the cycle threshold (Ct) was averaged from the values obtained in each reaction. VCAM-1, E-selectin and ICAM-1 mRNA expression results are reported as the increase (x-fold) using a 2 -⌬⌬ Ct mathematical method. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Applied Biosystems) was used as a housekeeping gene to normalize the results. TNF-␣ -activated endothelial cells were used as the calibrator in these experiments; its value was set at 1 and the other conditions were in relation to this reference value. Results are expressed as the mean and SD (error bars) of CAMs mRNA change relative to TNF-␣ alone.
Measurement of sCAMs Protein Secretion by HAECs
Stimulated with TNF-␣ Dose-and time-course response experiments were performed by stimulating HAECs with TNF-␣ . Once the appropriate experimental conditions were established, i.e. the capacity to measure minimal decreases in sCAMs protein secretion that may be induced by the compounds under investigation (in the present case AT and BAY; 1 M ), we opted for TNF-␣ at 10 ng/ml based on the concentrations used in previous reports with HUVECs [23, 26] or with HAECs [1, 19, 20, 25, 27, 28] .
At the conclusion of the experiments, cells and supernatants were separated by centrifugation (Multifuge 3L-R; Madrid, Spain) at 1,500 g for 10 min at 4 ° C. The cell pellet/debris was discarded and the cell-free supernatants used for sVCAM-1, sE-selectin, sICAM-1 measurements using enzyme-linked immunosorbent assays (ELISA) according to the manufacturer's protocol (for sVCAM-1 ELISA kit, Diaclone, Besançon, France; for sE-selectin and sICAM-1, Quantikine ELISA kits from R&D Systems, Madrid, Spain).
All experimental data were compared to the outcomes in the TNF-␣ -alone incubation, since this achieved the maximal secretion of sVCAM-1. A vehicle-alone control (vehicle for AT, absolute ethanol) was run in parallel and used as the control in this experiment. Results are expressed as the mean sCAMs protein secretion and SD (error bars).
Calcein Labeling of Jurkat T Cells
Calcein acetoxymethyl ester (calcein-AM, Molecular Probes, Eugene, Oreg., USA) was used to fluorescently label Jurkat T cells. Calcein is a nonfluorescent and lipophilic molecule which is cleaved by endogenous esterases and the resultant product's fluorescence can be measured at 485 and 530 nm (excitation and emission wavelengths, respectively).
The Jurkat T cells were fluorescently labeled by incubating cells (25 ! 10 6 cells/ml) with a final concentration of 5 M of calcein-AM for 30 min at 37 ° C and 5% CO 2 . After calcein-AM loading, the cells were washed twice with RPMI-1640 medium supplemented with 10% FBS to remove excess dye. Cells were finally resuspended in CM at a density of 2.5 ! 10 6 cells/ml.
Cell-Cell Adhesion Assay
HAECs were seeded until confluent in black 96-well tissue culture plates. Following the appropriate culture with AT and BAY, calcein-AM-labeled Jurkat T cells were cocultured (2.5 ! 10 5 cells/well) with the HAEC monolayer for 1 h at 37 ° C in a humidified atmosphere with 5% CO 2 . The nonadhered Jurkat T cells were removed from the HAEC monolayer by washing twice with CM. Fluorescence in each well of the culture plate was measured with the Synergy HT Fluorometer (BioTek Instruments, Alcobendas, Spain) [29, 30] . Results are expressed as relative fluorescence units and SD (error bars).
Statistical Analyses
Data were expressed as the mean and SD (error bars) for sCAMs protein concentration and CAMs mRNA expression. Unless otherwise stated, all experiments were performed at least twice and each incubation condition was set up in triplicate. Analysis of variance (ANOVA) with Bonferroni's correction was used for multiple comparisons. A value of p ! 0.05 was considered statistically significant.
A requisite for the analytical quality of the model was the control of several aspects involved in the cellular process and analytical performance of measurements. Thus, we evaluated the precision of the model by calculating the SD, SEM and the coefficients of variation (CV). All the results were analyzed with the Statistical Package for the Social Sciences (SPSS) software (version 19.0).
Results
Cytotoxicity
There was no evidence of HAEC cytotoxicity following exposure to AT (10, 25, 50, 75 and 150 M ) for 6 h ( fig. 1 a) nor TNF-␣ (10 ng/ml; fig. 1 b) for the subsequent 24 h. No cytotoxicity was observed, as assessed by LDH activity release, at the concentrations of BAY tested (1 M ) under these experimental conditions.
Effect of AT and BAY on CAMs mRNA Expression by HAECs Stimulated with TNF-␣
Exposure of cells to TNF-␣ (1 ng/ml for VCAM-1, 10 ng/ml for E-selectin and ICAM-1) for 24 h induced strong upregulation of CAMs mRNA expression ( fig. 2 ). As shown in figure 2 a, AT (at 50, 75 and 150 M ) significantly reduced VCAM-1 mRNA expression in TNF-␣ -stimulated HAECs by approximately 37% (p ! 0.05). The intra-assay CV was ! 20% and the inter-assay CV was ! 21%. Compared to TNF-␣ alone, BAY treatment (0.1 M ) significantly blocked TNF-␣ -induced VCAM-1 mRNA expression by approximately 25% (p ! 0.05; fig. 2 a) . The intra-and inter-assay CVs were ! 13%.
There was a tendency towards reducing E-selectin mRNA expression by BAY and AT by approximately 40 and 25%, respectively, but these reductions were not statistically significant ( fig. 2 b) . ICAM-1 mRNA expression was decreased by AT and BAY by 25-40% and 13%, respectively, compared to TNF-␣ stimulation. However, the decrease did not reach statistical significance ( fig. 2 c) .
Effects of AT and BAY on sCAMs Protein Secretion by
HAECs Stimulated with TNF-␣ When cells were exposed to TNF-␣ (10 ng/ml), sVCAM-1, sE-selectin and sICAM-1 increased significantly to 7.71 (0.40), 0.33 (0.08) and 13.31 (0.76) ng/ml, respectively (p ! 0.05; fig. 3 ). AT significantly reduced sVCAM-1 protein secretion by about 40% in the highest doses tested (50, 75 and 150 M ) compared to TNF-␣ alone (10 ng/ml; p ! 0.05) ( fig. 3 a) . No dose-response effect was observed. The inter-and intra-assay CVs were ! 12%. AT also reduced sE-selectin (between 5 and 29%) and sICAM-1 (between 5 and 16%) at all doses tested, but the decreases did not reach statistical significance.
BAY (1 M ) reduced TNF-␣ (10 ng/ml) effects on sVCAM-1, sE-selectin and sICAM-1 release by 53, 50 and 26%. Only the effects on sVCAM and sE-selectin were statistically significant (p ! 0.05; fig. 3 a-c) . As shown in figure 3 b and c, nonactivated HAECs did not appear to release sE-selectin (limit of detection ! 0.125 ng/ml) and sICAM-1 (limit of detection ! 1.56 ng/ml), but the nonactivated cells did express sVCAM-1 (2.12 ng/ml; fig. 3 a) . Treatment of HAECs with AT had no statistically significant reduction effect on the protein secretion of sE-selectin (between 5 and 29% reduction) or sICAM-1 (between 6 and 16% reduction).
Effect of AT and BAY on Lymphocyte Cell Adhesion to HAECs
Qualitatively ( fig. 4 ) , there appeared to be a considerable number of Jurkat T cells adhering to TNF-␣ -treated HAECs, while very few cells adhered to untreated HAECs. Adhesion to HAECs that had been incubated with BAY (0.5, 1, 2 and 5 M ) appeared to be greatly decreased. Adhesion to HAECs that had been preincubated with AT (10, 25, 50, 75 and 150 M ) for 6 h appeared to decrease the adhesion of HAECs to Jurkat T cells at all concentrations tested ( fig. 4 ) .
The cell fluorescence images revealed that exposure of cells to TNF-␣ (10 ng/ml) for 24 h induced strong adhesion between Jurkat T cells and HAECs ( fig. 5 ) . The effects of different concentrations of AT and BAY on TNF-␣ -induced cell surface adhesion molecule expression are depicted in figure 5 . AT failed to modulate significantly the TNF-␣ -induced cell surface expression of CAMs at any of the concentrations (a reduction of between 11 and 17%; fig. 5 ). In contrast, when treated with BAY (0.1, 1, 2 and 5 M ), the TNF-␣ -induced cell surface expression of CAMs was notably reduced to 7, 13, 57 and 77%, respectively; statistically significant reductions being observed only at 2 and 5 M (p ! 0.05).
Discussion
Our results indicate that treatment with AT (50, 75 and 150 M ) inhibits VCAM-1 mRNA and sVCAM-1 protein by between 36 and 40% in TNF-␣ -stimulated HAECs (p ! 0.05). In contrast, when we analyzed the effects of AT on stimulated HAECs, we observed a nonsignificant decrease in E-selectin and ICAM-1 mRNA expression (40 and 25-40%, respectively) and in sE-selectin and sICAM-1 protein release (5-29 and 5-16%, respectively) compared to TNF-␣ alone (10 ng/ml). As such, AT appears to play a beneficial role in atherosclerosis by specifically reducing VCAM-1 but not the other CAMs studied, which were E-selectin and ICAM-1.
The optimum serum concentration of AT in humans is around 23.2 M [31] , which is similar to the concentrations selected for our investigation. We also observed that, in TNF-␣ -stimulated HAECs, BAY (at 0.1 M ) reduced VCAM-1 mRNA expression by 25% and sVCAM-1 protein release by 53% (p ! 0.05). Similarly, BAY (at 1 M ) decreased E-selectin and ICAM-1 mRNA expression by 25 and 13%, respectively, and sE-selectin and sICAM-1 protein release by 50 and 26%, respectively; albeit these reductions were not statistically significant.
VCAM-1 is an important adhesion molecule that is upregulated during endothelial activation by various factors such as TNF-␣ . Belonging to the immunoglobulin superfamily, it has adhesion molecule properties and acts as a ligand for activated leukocyte adhesion to endothelium [32] .
Garton et al. [33] demonstrated in mice that VCAM-1 is released as a soluble form of the extracellular domain that is generated by TNF-␣ -converting enzymes (TACE or ADAM 17) induced by phorbol 12-myristate 13-acetate. E-selectin is expressed in acute as well as in a chronically inflamed endothelium and induces rolling of circulating monocytes and/or leukocytes through this endothelium [34, 35] .
ICAM-1 is also involved in atherosclerosis, presumably through the regulation of monocyte recruitment into atherosclerosis-prone areas. ICAM-1 expression is elevated in aortas that are predisposed to atherosclerosis and is regulated by proinflammatory stimuli such as that of TNF-␣ . E-selectin is involved in the leukocyte rolling on the endothelium, while VCAM-1 and ICAM-1 are involved in firm adhesion of leukocytes by binding to very late antigen-4 and to leukocyte function antigen-1, respectively. This mechanism is in accordance with our findings in the functional experiments in which we observed no differences between leukocyte adhesion to activated HAECs in the presence or absence of AT.
With respect to the proteins of each individual sCAM, we observed different degrees of response to the same stimuli (TNF-␣ 10 ng/ml) for each sCAM (13.31 ng/ml for sICAM-1, 7.71 ng/ml for sVCAM-1, and 0.33 ng/ml for sE-selectin); the contribution of each one being different in the adhesion step of atherosclerosis. Deneva-Koycheva et al. [36] recently determined the reference ranges of sVCAM-1 (170.42-478.36 ng/ml), sE-selectin (9.15-65.19 ng/ml) and sICAM-1 (128.9-347.48 ng/ml) in the serum of healthy Bulgarians, with no gender-related differences in CAM concentrations (p 1 0.05). Human CAM serum concentrations are higher than those selected for the present study. BAY, at 1 and 0.1 M in the present study, reduced both sVCAM-1 protein release and VCAM-1 mRNA expression (p ! 0.05). BAY (1 M ) also reduced sE-selectin and sICAM-1 protein release as well as their mRNA expression, albeit without the reduction being statistically significant. At similar concentrations (2, 5 or 12 M ) BAY has previously been described as inhibiting NF-B in different cell types [37] [38] [39] . Accordingly, in our study, protein release of the studied sCAMs was reduced as well as the adhesion between activated HAECs and Jurkat T cells by BAY (0.5, 1, 2 and 5 M ); statistical significance being reached at BAY concentrations of 2 and 5 M (p ! 0.05).
Based on previous reports on HUVECs [23, 26] and in HAECs [1, 19, 20, 25, 28] in which the effects of compounds other than AT had been tested, we added TNF-␣ (at 10 ng/ml) to the HAEC culture for 24 h to determine the sVCAM-1 protein release. A mean of 74.74 pg/ml (range: 64-84) serum TNF-␣ concentration was recorded in healthy children [40] and, as reported by Tomiyama et al. [41] , control individuals have 1.7 8 0.5 pg/ml TNF-␣ in their circulation, while patients with obstructive sleep apnea have nearly 2 pg/ml. Patients with systemic lupus erythematosus have 4.9 8 12.8 pg/ml and those with rheumatoid arthritis (an inflammatory disease) have 20 8 36.2 pg/ml [42, 43] . Hence, under inflammatory conditions, serum TNF-␣ levels can be high, approaching the TNF-␣ levels used in this study.
The production of adhesion molecules by endothelial cells has been shown to be regulated by redox-sensitive signal transduction and, thus, may be subjected to modulation by oxidants and antioxidants [44] . Since AT is a potent antioxidant, it would be reasonable to assume that the effects of this compound on reducing sVCAM-1 protein release in activated HAECs may be mainly due to its antioxidant properties in several endothelial cell types [21] . These outcomes are also observed at the mRNA expression level. Hence the results demonstrate that, apart from its antioxidant activities, AT can exert a modest inhibitory effect on adhesion molecule expression in vitro, and this suggests an improvement in endothelial dysfunction in HAECs.
It has been argued that HAECs or HUVECs may not adequately represent inflammatory changes in the microcirculation in tissues since these cells are isolated from a large artery or vein, respectively. The microvascular cell line HMEC-1 is reportedly one of the endothelial cell lines most similar to primary endothelium [21] . Results of sVCAM-1 in HMEC-1 cultures have shown wider variation than those from HUVEC experiments, and it is mainly for this reason that HUVECs have been used extensively in in vitro endothelium studies [45] . It is not clear, however, whether these differences render HMEC-1 a better or a poorer model of local inflammation than HUVECs. However, HUVECs provide more consistent results even if genetic differences between donors may result in wider variation in the expression of inflammation markers [45] . Further cell culture studies are required using HMEC-1 or human coronary artery endothelial cells to confirm the sVCAM-1 results that had been observed in HAECs [38] .
Conclusion
Our results suggest that the effect of AT on mRNA expression was the cause of decreased rates of the cleaved soluble protein products of CAMs. However, the effect of BAY on decreasing CAMs mRNA expression was less than the decrease in the rates of their soluble protein products. The possible mechanism of action could be an inhibition of proteolytic cleavage to liberate the circulating form of sVCAM-1, or of alternative splicing. AT (at 50, 75 and 150 M ), apart from having antioxidant and anti-inflammatory properties, also reduced VCAM-1 mRNA expression and sVCAM-1 protein release, while BAY (at 1 M ) reduced all CAMs studied (VCAM-1, E-selectin and ICAM-1) and also reduced the overall adhesion between HAECs and Jurkat T cells, thus implying an improvement in endothelial dysfunction that had been induced by TNF-␣ . This in vitro model has its uses in assessing the potential beneficial effects of natural and manufactured compounds developed for the treatment of endothelium dysfunction and atherosclerosis.
